Clinical Trial Update: Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating the combination of tocotrienol and bevacizumab for metastatic colorectal cancer. The trial is sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Tocotrienol (tocotrienol (vitamin E) supplement)

Snippet

Sponsor: Vejle Hospital | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING